Black patients hospitalized with coronavirus disease 2019 from an urban academic medical center in New York City exhibited high rates of comorbidities and in-hospital mortality, with chronic obstructive pulmonary disease and asthma significantly linked with early death.
Black patients hospitalized with coronavirus disease 2019 (COVID-19) from an urban academic medical center in New York City exhibited high rates of present comorbidities and in-hospital mortality, with chronic obstructive pulmonary disease (COPD) and asthma significantly linked with early death, according to a study published this week in BMC Infectious Diseases.
As researchers highlight, African-American/Black patients have represented a higher risk of morbidity and mortality due to COVID-19 than any other racial group. “Such burden of disease is of particular concern since it disproportionately affects communities with considerable health disparities in New York City, where African-Americans and Latinos constitute as much as 53% of the population,” noted researchers.
Examining patients with COVID-19 hospitalized at the State University of New York, Downstate Medical Center, Brooklyn, New York, researchers sought to assess potential causes of disparities in COVID-19 outcomes, as well as delineate prognostic indicators and assess effectiveness of treatment interventions in patient care. The facility is a designated COVID-only facility serving a majority Black population.
The researchers performed a retrospective cohort study of clinical features and laboratory data of patients with COVID-19 (N = 529) admitted over a 52-day period at the height of the pandemic in the United States (March 2–April 23).
Among the patient cohort, 88% were Black, of whom more than half (52%) were aged 61 to 80 years with a mean body mass index of 30 kg/m2, indicating obesity. Virtually all (98%) presented with 1 or more preexisting condition. The most common comorbidities included hypertension (79%) and diabetes (56%); 17 % had chronic kidney disease (CKD).
For patients with CKD, those who received hemodialysis were found to have lower mortality than patients who did not receive it. The presence of coronary artery disease was also found to be an independent predictor of mortality among patients with CKD in the multivariate analysis.
Notably, time to death modeling conducted via Cox proportional hazards represented a significantly higher hazard ratio (HR) for death in patients with the paired comorbidites of COPD and asthma (HR = 1.79; CI, 1.20–2.68; P = .005). This analysis additionally showed that patients who had pre-admission ACE inhibitors (P = .013) and ARBs (P = .013) had a beneficial effect.
Nearly half of the assessed inpatients (n = 255; 48%) died, with more than one-third of those patients dying within 3 days of admission (Black, n = 78; others, n = 13). Of the 159 patients who received invasive mechanical ventilation, 86% died.
“Patients with COVID-19 in our predominantly Black neighborhood had higher in-hospital mortality, likely due to higher prevalence of comorbidities,” concluded researchers. “Early escalation of care based on comorbidities and key laboratory indicators is critical for improving outcomes in Black patients.”
Reference
Gupta R, Agrawal R, Bukhari Z, et al. Higher comorbidities and early death in hospitalized African-American patients with COVID-19. BMC Infect Dis. Published online January 18, 2020. doi:10.1186/s12879-021-05782-9
A Pulmonologist on Why You Should Think About Respiratory Health and the Lungs
November 16th 2021On this episode of Managed Care Cast, we speak with MeiLan K. Han, MD, MS, the author of a book released this month called Breathing Lessons: A Doctor’s Guide to Lung Health. Han, a pulmonologist, gives an inside tour of the lungs and how they work, zooms out to examine the drivers of poor respiratory health, and addresses policy changes that are needed to improve lung health.
Listen
Study: 1 in 6 US Patients With COPD Suffer From Cost-Related Medication Nonadherence
April 3rd 2024Medication nonadherence among patients with chronic obstructive pulmonary disease (COPD) is associated with increasing COPD symptoms, hospitalizations, morbidity, mortality, and health care expenditures.
Read More
Similar In-Hospital, Long-Term Survival Rates Found Among Male, Female Patients With AECOPD
March 18th 2024This study analyzed sex differences among patients with acute exacerbations of chronic obstructive pulmonary disease (AECOPD), with findings indicating that female smokers experience worse hospital outcomes despite similar overall survival rates.
Read More